Cargando…
Efficacy of Omalizumab Therapy in an Asthmatic with Low IgE
Asthma is one of the most common respiratory diseases encountered in clinical practice. Although the vast majority of asthmatics can be adequately controlled with inhaled steroids and other preventer medications, a small proportion remain uncontrolled. Anti-IgE treatment with omalizumab has been pro...
Autores principales: | R, Divya, Venkitakrishnan, Rajesh, Augustine, Jolsana, Cleetus, Melcy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520673/ https://www.ncbi.nlm.nih.gov/pubmed/33014501 http://dx.doi.org/10.1155/2020/8898454 |
Ejemplares similares
-
Pneumothorax ex vacuo: Three cases of an uncommon entity
por: Venkitakrishnan, Rajesh, et al.
Publicado: (2023) -
Biological therapy for severe asthma – Indian perspectives and challenges
por: Venkitakrishnan, Rajesh, et al.
Publicado: (2023) -
Casirivimab - Imdevimab in Covid 19 – Early Indian experience
por: Venkitakrishnan, Rajesh, et al.
Publicado: (2022) -
COVID-19 presenting as acute transient flaccid limb paralysis
por: Rajesh, V, et al.
Publicado: (2021) -
Inhaled Formoterol-Fluticasone Single Inhaler Therapy in Asthma: Real-World Efficacy, Budget Impact, and Potential to Improve Adherence
por: Rajesh, V., et al.
Publicado: (2020)